Literature DB >> 12667278

Neonatal resuscitation.

Thomas E Wiswell1.   

Abstract

Ten million or more newborns worldwide each year need some type of resuscitation assistance. More than 1 million babies die annually from complications of birth asphyxia. Over the past 3 decades, neonatal resuscitation has evolved from disparate, word-of-mouth teaching methods to organized programs. The most widely-used curriculum is the Neonatal Resuscitation Program, which is supported by the American Academy of Pediatrics and the American Heart Association. To date more than 1.5 million individuals have been trained in the Neonatal Resuscitation Program. Resuscitation efforts are geared toward avoiding or mitigating the adverse sequelae of asphyxia neonatorum. Certain characteristics distinguish the preterm infant, including propensity to become hypothermic and higher potential for adverse neurologic and pulmonary complications from resuscitation efforts. In this era of evidence-based medicine the most recent Neonatal Resuscitation Program guidelines were developed to provide recommendations based on the best currently-available science. A number of major proposals received considerable scrutiny during the evaluation process. Many areas of neonatal resuscitation still need to be studied.

Entities:  

Mesh:

Year:  2003        PMID: 12667278

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  3 in total

1.  Effectiveness of Nursing Risk Management in Neonatal Asphyxia Resuscitation Care.

Authors:  Zhen Ye; Wenjun Wang; Peili Sun
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-03       Impact factor: 2.650

2.  Tension pneumothorax in a newborn after Cesarean-section delivery -A case report-.

Authors:  Sang Kwon Kim; Won Ho Kim
Journal:  Korean J Anesthesiol       Date:  2010-12-31

3.  Neonatal resuscitation after severe asphyxia--a critical evaluation of 177 Swedish cases.

Authors:  Sophie Berglund; Mikael Norman; Charlotta Grunewald; Hans Pettersson; Sven Cnattingius
Journal:  Acta Paediatr       Date:  2008-06       Impact factor: 2.299

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.